Literature DB >> 9493590

4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction.

F Burzotta1, A Di Castelnuovo, C Amore, A D'Orazio, R Di Bitondo, M B Donati, L Iacoviello.   

Abstract

The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene-environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493590

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Authors:  Francesco Burzotta; Licia Iacoviello; Augusto Di Castelnuovo; Roberto Zamparelli; Andria D'Orazio; Concetta Amore; Rocco Schiavello; Maria Benedetta Donati; Attilio Maseri; GianFederico Possati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery.

Authors:  Gonzalo Sirgo; José Luis Pérez-Vela; Pablo Morales; Manuel Del Rey; Joan Vendrell; Cristina Gutierrez; Jordi Rello
Journal:  Intensive Care Med       Date:  2006-03-01       Impact factor: 17.440

3.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.

Authors:  Gotho Geishofer; Alexander Binder; Martin Müller; Bettina Zöhrer; Bernhard Resch; Wilhelm Müller; Jörg Faber; Adam Finn; Georg Endler; Christine Mannhalter; Werner Zenz
Journal:  Eur J Pediatr       Date:  2005-04-21       Impact factor: 3.183

Review 4.  Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.

Authors:  K Huber
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

Review 5.  Fibrinolytic function and coronary risk.

Authors:  I Juhan-Vague; P Morange; M Christine Alessi
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

6.  Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.

Authors:  Dina M R Shammaa; Amira S Sabbagh; Ali T Taher; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

7.  PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.

Authors:  Shangqian Wang; Qiang Cao; Xiaoxiang Wang; Bingjie Li; Min Tang; Wanqing Yuan; Jianzheng Fang; Jian Qian; Chao Qin; Wei Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.

Authors:  Xia Xu; Hongchao Wang; Haijun Li; Xiaopei Cui; Hongyu Zhang
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

9.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.

Authors:  Zaid H Al-Hamodi; Riyadh Saif-Ali; Ikram S Ismail; Khaled A Ahmed; Sekaran Muniandy
Journal:  J Clin Biochem Nutr       Date:  2011-11-11       Impact factor: 3.114

10.  The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera.

Authors:  Ozgür Mehtap; Elif Birtaş Ateşoğlu; Pınar Tarkun; Emel Gönüllü; Hakan Keski; Yıldıray Topçu; Nilüfer Uzülmez; Deniz Sünnetçi; Abdullah Hacıhanefioğlu
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.